Dogwood Therapeutics Inc.

NASDAQ: DWTX · Real-Time Price · USD
4.82
-0.08 (-1.63%)
At close: Sep 18, 2025, 3:59 PM
4.96
2.90%
After-hours: Sep 18, 2025, 07:35 PM EDT

Dogwood Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
13.4M 17.54M 14.85M 2.04M 3.02M 2.38M 3.32M 4.79M 4.59M 5.33M 7.03M 9.79M 7.7M 11.35M 14.01M 19.19M 21.84M 24.59M
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
19.13K 18.15K 18.13K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Receivables
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets
43.52K 71.59K 28.01K 20.84K 35.07K 52.24K 3.56K 18.82K 32.11K 53.91K 7.29K 13.68K 25.38K 34.07K 863.00 21.08K 757.00 n/a
Total Current Assets
14.7M 19.16M 16.54M 2.28M 3.64M 3.22M 4.17M 5.25M 5.21M 6.52M 8.37M 10.86M 9.04M 12.55M 15.78M 20.11M 23.76M 28.27M
Property-Plant & Equipment
207.14K 209.66K 222.65K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Goodwill & Intangibles
81.76M 77.59M 77.52M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
81.99M 77.82M 84.67M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Assets
96.69M 96.98M 94.31M 2.28M 3.64M 3.22M 4.17M 5.25M 5.21M 6.52M 8.37M 10.86M 9.04M 12.55M 15.78M 20.11M 23.76M 28.27M
Account Payables
n/a 1.15M 1.23M 454.96K 217.76K 196.76K 111.91K 205.37K 214.31K 135.09K 573.16K 679.42K 665.54K 330.69K 353.86K 483.5K 262.59K 614.66K
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 44.19K
Short-Term Debt
54.5K 50.72K 49.7K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Liabilities
1.33M 1.07M 687.59K n/a 55.92K 93.97K n/a 46.8K 62.73K 93.15K 159.7K 261.35K 346.5K 236.85K 532.68K 459.06K 345.31K 226.93K
Total Current Liabilities
1.89M 2.58M 3.18M 1.33M 500.08K 570.08K 358.55K 487.14K 520.03K 549.29K 1.04M 1.63M 1.9M 1.88M 1.28M 1.23M 906.26K 1.17M
Long-Term Debt
75.66M 75.66M 15.38M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities
87.93M 87.32M 26.85M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Liabilities
89.81M 89.9M 30.03M 1.33M 500.08K 570.08K 358.55K 487.14K 520.03K 549.29K 1.04M 1.63M 1.9M 1.88M 1.28M 1.23M 906.26K 1.17M
Total Debt
75.85M 75.85M 15.59M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Book Value
6.88M 7.09M 64.28M 949.43K 3.14M 2.65M 3.81M 4.76M 4.69M 5.97M 7.33M 9.22M 7.14M 10.67M 14.5M 18.88M 22.86M 27.11M
Book Value Per Share
3.60 4.92 49.05 0.86 3.42 3.45 4.94 6.23 6.37 8.14 9.99 25.07 21.43 32.03 43.52 56.66 68.60 81.39
Common Stock
191.00 191.00 133.00 111.00 2.78K 1.93K 77.00 1.93K 1.86K 1.83K 1.83K 1.83K 833.00 833.00 833.00 833.00 833.00 833.00
Retained Earnings
-88.55M -84.74M -73.82M -66.09M -63.81M -62.76M -61.47M -60.37M -59.13M -57.69M -56.17M -54.13M -51.55M -47.89M -43.93M -39.41M -35.3M -31.02M
Comprehensive Income
-267.29K -3.8M -3.86M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shareholders Equity
14.15M 7.09M 64.28M 949.43K 3.14M 2.65M 3.81M 4.76M 4.69M 5.97M 7.33M 9.22M 7.14M 10.67M 14.5M 18.88M 22.86M 27.11M
Total Investments
19.13K 18.15K 18.13K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a